SWiMS - Schizophrenia Weight, Metformin and Semaglutide: A double blind double dummy placebo controlled multi-centre RCT

  • Siskind, Dan J. (Primary Chief Investigator (PCI))
  • Russell, Anthony (Chief Investigator (CI))
  • Berk, Michael (Chief Investigator (CI))
  • Yung, Alison (Chief Investigator (CI))
  • Harris, Anthony W.F. (Chief Investigator (CI))
  • Lappin, Julia M. (Chief Investigator (CI))
  • Kisely, Steve R. (Chief Investigator (CI))
  • Schubert, Oliver (Chief Investigator (CI))
  • Jayaram, Mahesh B. (Chief Investigator (CI))
  • Arnautovska, Urska (Chief Investigator (CI))

Project: Research

Project Details

AcronymSWiMS
StatusActive
Effective start/end date1/02/2231/01/28

Funding

  • Medical Research Future Fund (MRFF): A$3,839,117.60